Market Indices
Latest News
 |
Champions Oncology, Inc. (CSBR) confirmed earnings release on July 20, 2026,...
July 20, 2026 CSBR 0.32% |
| ||
| ||
| ||
|
Price Targets
Thomas Flaten from Lake Street issued a price target of $16.25 for PSNL on 2026-07-20 14:08:03.The adjusted price target was set to $16.25.At the time of the announcement,
July 20, 2026 PSNL -13.78%
from Evercore ISI issued a price target of $158.00 for BNY on 2026-07-20 12:48:59.The adjusted price target was set to $158.00.At the time of the announcement, BNY...
July 20, 2026 BNY -0.13%
Greg Palm from Craig-Hallum issued a price target of $7.00 for NNBR on 2026-07-20 11:20:48.The adjusted price target was set to $7.00.At the time of the announcement, NNBR...
July 20, 2026 NNBR 7.70%
Patrick Trucchio from H.C. Wainwright issued a price target of $7.50 for ATAI on 2026-07-20 11:17:19.The adjusted price target was set to $7.50.At the time of the announcement,
July 20, 2026 ATAI -0.48%
Market Movers
| Top Gainers (%) | |||||||||||||||||||
| SYRS Syros Pharmaceuticals, In | 0.00
100.00% | ||||||||||||||||||
| WGSWW GeneDx Holdings Corp. | 0.00
25.00% | ||||||||||||||||||
| STIM Neuronetics, Inc. | 2.01
23.77% | ||||||||||||||||||
| PSQH PSQ Holdings, Inc. | 3.38
12.29% | ||||||||||||||||||
| PRE Prenetics Global Limited | 20.17
10.28% | ||||||||||||||||||
| UONEK Urban One, Inc. | 4.53
10.22% | ||||||||||||||||||
| SOPH SOPHiA GENETICS S.A. | 6.45
9.88% | ||||||||||||||||||
| REKR Rekor Systems, Inc. | 0.62
9.41% | ||||||||||||||||||
Annual/Quarterly Reports Summary
In a landscape marked by rapid technological advancements, the company saw a revenue increase of $1.4 million for the three months ending September 30, 2024, fueled by new licenses and...
November 6, 2024 AIP -0.81%
In a landscape of fluctuating revenues, the company celebrated a 25% revenue increase in Q3 2024, yet faced a 14% decline over nine months due to production challenges. Operating expenses...
November 6, 2024 EOSEW -34.96%
In a landscape marked by financial challenges, the company faced fluctuating revenues, with a notable 25% increase in Q3 2024 overshadowed by a 14% decline over nine months. Operating losses...
November 6, 2024 EOSE -2.91%
In a tale of growth and ambition, the company witnessed its revenue soar from $6.0 million to $13.9 million, fueled by partnerships with Acadia Pharmaceuticals. However, operating expenses, particularly in...
November 5, 2024 STOK -3.82%
In a transformative period, the company experienced a remarkable surge in revenue, driven by newly acquired oil and gas assets. Operating expenses showed notable trends, with a decrease in occupancy...
November 5, 2024 BSVN -1.81%